Cite
HARVARD Citation
O'Donnell, E. et al. (2018). A phase 2 study of modified lenalidomide, bortezomib and dexamethasone in transplant‐ineligible multiple myeloma. British journal of haematology. pp. 222-230. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
O'Donnell, E. et al. (2018). A phase 2 study of modified lenalidomide, bortezomib and dexamethasone in transplant‐ineligible multiple myeloma. British journal of haematology. pp. 222-230. [Online].